-
Gilenya Treatment Primarily Reduces B-Cells and T Helper Cells in RRMS Patients, Study Finds
Treatment with the immune-modulating therapy Gilenya specifically reduced the numbers of B-cells and T helper cells in people with RRMS, a study found. Click here to read more.
What do you think about this study and its findings?
Sorry, there were no replies found.
Log in to reply.